News

Elpiscience BioPharma and Bio-Techne Corporation announced that the companies have entered into a strategic collaboration for the development of anti-cancer therapeutics. Under the…
Read More...

Eli Lilly and Company and Avidity Biosciences, Inc. announced a global licensing and research collaboration focused on the discovery, development and commercialization of potential new…
Read More...

Teva Pharmaceutical Industries Ltd. announced the launch of a generic version of VESIcare ®1 (solifenacin succinate) Tablets, 5 mg and 10 mg, in the U.S. Solifenacin Succinate…
Read More...

Pfizer Inc. and Eli Lilly and Company announced top-line results from a Phase 3 study evaluating tanezumab 2.5 mg and 5 mg. The objective of the study was to compare the long-term joint…
Read More...

Non-profit drug developer, TB Alliance, and pharmaceutical company, Mylan N.V. announced a global collaboration to make the experimental drug pretomanid accessible for use in two…
Read More...

Ipsen and Clementia Pharmaceuticals announced the closing of Ipsen’s acquisition of Clementia following approval of the arrangement by Clementia shareholders and the Quebec Superior…
Read More...

SK Biopharmaceuticals, a pharmaceutical company focused on disorders of central nervous system and cancer, and twoXAR, Inc., an artificial intelligence (AI)-driven biopharmaceutical…
Read More...

PureTech Health plc, an advanced biopharmaceutical company developing novel medicines for dysfunctions of the Brain-Immune-Gut (BIG) axis, announced that it has entered into a research…
Read More...

CASI Pharmaceuticals, a U.S. pharmaceutical company with a platform to develop and accelerate the launch of innovative therapeutics and pharmaceutical products in China, the U.S., and…
Read More...

STC Biologics (www.stcbiologics.com) announced that it has completed construction of a single-use mammalian GMP manufacturing facility in Newton, Massachusetts, and that it has…
Read More...

I-Mab Biopharma, a biotech company focusing exclusively on innovative biologics in immuno-oncology and auto-immune diseases, and WuXi Biologics, a leading global open-access biologics…
Read More...

Efforts to discover novel compounds against Chagas disease see early successes – part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards programme to fast track drug…
Read More...

MS Pharma, a fast growing pharmaceutical company based in Jordanand operating across the Middle East, Turkey and Africa, announced that it has entered into an agreement to acquire 100%…
Read More...

Recro Pharma, a specialty pharmaceutical company with a high-performing revenue generating contract development and manufacturing (CDMO) division, announced that Recro Gainesville LLC,…
Read More...

Gilead Sciences Inc. and insitro announced today that the companies have entered into a strategic collaboration to discover and develop therapies for patients with nonalcoholic…
Read More...

Greenfield Global Inc., Canada's largest producer of alcohol and fuel ethanol, and one of the largest alcohols and solvents companies in North America, has announced plans to establish…
Read More...

Fibrocell Science announced the completion of a collaboration agreement with Castle Creek Pharmaceuticals to develop and commercialize Fibrocell’s lead gene therapy candidate, FCX-007,…
Read More...

Adare Pharmaceuticals announced that it has entered into an agreement with Egalet Corporation, to acquire global rights of the “Parvulet” technology platform and its associated…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) accepted the company's Biologics License Application (BLA) for brolucizumab (RTH258) for the treatment of wet…
Read More...

Alnylam Pharmaceuticals announced that the Company has initiated ILLUMINATE-B, a global Phase 3 pediatric study of lumasiran, an investigational, subcutaneously administered RNAi…
Read More...